Douglas A Roeder's Net Worth
$1.27 Million
Who is Douglas A Roeder?
Douglas A Roeder has an estimated net worth of $1.27 Million. This is based on reported shares across multiple companies, which include TRANS1 INC, ALDER BIOPHARMACEUTICALS INC, TriVascular Technologies, Inc., TANDEM DIABETES CARE INC, Senseonics Holdings, Inc., and Calithera Biosciences, Inc..
SEC CIK
Douglas A Roeder's CIK is 0001270735
Past Insider Trading and Trends
2021 was Douglas A Roeder's most active year for acquiring shares with 5 total transactions. Douglas A Roeder's most active month to acquire stocks was the month of April. 2021 was Douglas A Roeder's most active year for disposing of shares, totalling 7 transactions. Douglas A Roeder's most active month to dispose stocks was the month of July. 2021 saw Douglas A Roeder paying a total of $345,155.05 for 280,327 shares, this is the most they've acquired in one year. In 2021 Douglas A Roeder cashed out on 708,355 shares for a total of $1,494,786.65, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALDER BIOPHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +36.45% | 2.84M |
$10.00 | $3,500,000.00 | 10.63M |
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TriVascular Technologies, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.54M |
—
|
—
|
0
|
Feb 3
| |||
Form 4
| -100.00% | -3.54M |
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
∞
| 3.54M |
$12.00 | $9,999,996.00 | 3.54M |
Nov 1 - Apr 22
| |||
Form 4
|
∞
| 3.54M |
$12.00 | $9,999,996.00 | 3.54M |
Nov 1 - Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TANDEM DIABETES CARE INC (TNDM) Snapshot price: $42.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.21K |
—
|
—
| 2.21K |
May 18
| |||
Form 4
| -99.44% | -1.00M |
—
|
—
| 5.66K |
Scheduled
|
Oct 15
| ||
Form 4
|
—
|
0
|
—
|
—
| 992.22K |
Jun 23
| |||
Form 4
|
∞
| 1.89K |
—
|
—
| 1.89K |
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
| -8.78% | -308.30K |
$70.51 | -$21,680,376.25 | 3.2M |
Scheduled
|
Aug 27 - Aug 28
| ||
Form 4
| -0.72% | -9.47K |
$70.01 | -$663,076.07 | 1.31M |
Scheduled
|
Aug 2
| ||
Form 4
| -1.00% | -13.35K |
$70.08 | -$935,375.11 | 1.32M |
Scheduled
|
Jul 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| -2.61% | -35.69K |
$70.07 | -$2,500,647.46 | 1.33M |
Scheduled
|
Jun 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
| +272.63% | 1M |
$2.00 | $2,000,000.00 | 1.37M |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
∞
| 3.67M |
—
|
—
| 3.67M |
Nov 19
| |||
Form 4
|
∞
| 3.67M |
—
|
—
| 3.67M |
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Senseonics Holdings, Inc. (SENS) Snapshot price: $0.3225
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.25% | 236.34K |
—
|
—
| 1.04M |
May 22
| |||
Form 4
| +59.06% | 300K |
$0.54 | $162,000.00 | 807.99K |
Aug 30
| |||
Form 4
| +64.94% | 200K |
$0.75 | $150,000.00 | 507.99K |
Jun 9
| |||
Form 4
| +92.44% | 147.95K |
—
|
—
| 307.99K |
May 17
| |||
Form 4
| +164.60% | 99.56K |
—
|
—
| 160.04K |
May 26
| |||
Form 4
| -67.45% | -125.34K |
$2.58 | -$867,457.75 | 60.48K |
Aug 24 - Aug 25
| |||
Form 4
| -31.95% | -87.25K |
$1.91 | -$282,173.85 | 185.82K |
Scheduled
|
May 25
| ||
Form 4
| -100.00% | -652.00 |
$2.08 | -$1,358.38 |
0
|
May 19
| |||
Form 4
| -66.80% | -9.85M |
$2.26 | -$22,184,832.48 | 4.89M |
Scheduled
|
Apr 9 - Apr 12
| ||
Form 4/A
|
∞
| 273.08K |
—
|
—
| 273.08K |
Jul 20
| |||
Form 4
|
∞
| 273.08K |
—
|
—
| 273.08K |
Jul 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
| -3.07% | -980.39K |
$3.99 | -$3,938,425.46 | 30.92M |
Scheduled
|
Jun 13 - Jun 15
| ||
Form 4
| -2.32% | -519.61K |
$3.88 | -$2,011,296.14 | 21.92M |
Scheduled
|
Jun 11 - Jun 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
| +12.14% | 1.23M |
$2.85 | $3,499,999.50 | 11.35M |
Mar 23
| |||
Form 4
| +12.14% | 1.23M |
$2.85 | $3,499,999.50 | 11.35M |
Mar 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Calithera Biosciences, Inc. (CALA) Snapshot price: $0.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.43M |
$10.00 |
—
| 2.43M |
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||